- Report
- April 2022
- 40 Pages
Ireland
From €2465EUR$2,595USD£2,114GBP
- Report
- April 2022
- 40 Pages
Japan
From €2465EUR$2,595USD£2,114GBP
- Report
- April 2022
- 40 Pages
Russia
From €2465EUR$2,595USD£2,114GBP
- Report
- April 2022
- 40 Pages
Saudi Arabia
From €2465EUR$2,595USD£2,114GBP
- Report
- April 2022
- 40 Pages
South Korea
From €2465EUR$2,595USD£2,114GBP
- Report
- April 2022
- 40 Pages
United States
From €2465EUR$2,595USD£2,114GBP
- Report
- April 2022
- 40 Pages
Vietnam
From €2465EUR$2,595USD£2,114GBP
- Report
- March 2022
- 100 Pages
Global
From €4555EUR$4,795USD£3,906GBP
- Report
- September 2019
- 40 Pages
India
From €2465EUR$2,595USD£2,114GBP
- Report
- September 2019
- 100 Pages
Global
From €4555EUR$4,795USD£3,906GBP
- Report
- June 2022
- 99 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Drug Pipelines
- March 2021
Global
From €1900EUR$2,000USD£1,629GBP
- Drug Pipelines
- September 2020
- 49 Pages
Global
From €3325EUR$3,500USD£2,851GBP
- Drug Pipelines
- November 2018
- 70 Pages
Global
From €3325EUR$3,500USD£2,851GBP
- Report
- September 2019
- 40 Pages
Russia
From €2465EUR$2,595USD£2,114GBP
- Report
- September 2019
- 40 Pages
Ireland
From €2465EUR$2,595USD£2,114GBP
- Report
- September 2019
- 40 Pages
Germany
From €2465EUR$2,595USD£2,114GBP
- Report
- September 2019
- 40 Pages
France
From €2465EUR$2,595USD£2,114GBP
- Report
- September 2019
- 80 Pages
Africa
From €3605EUR$3,795USD£3,092GBP
Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more